News
AAX Biotech and evitria partner on antibody development
5+ hour, 23+ min ago (348+ words) Biotechnology company AAX Biotech has announced a new partnership with evitria AG to strengthen their early-stage antibody development. AAX Biotech, known for developing technologies for antibody-based therapies, will collaborate with evitria, a specialist provider of antibody engineering and expression services,…...
AI system detects pain in laboratory mice through facial analysis
2+ day, 5+ hour ago (606+ words) An automated imaging system developed at ETH Zurich uses AI to detect pain in laboratory mice through facial expression analysis, offering standardised assessment that reduces observer bias and animal stress." A white plastic box with an"orange floor may not…...
10x Genomics launches Atera whole-transcriptome spatial biology platform
1+ week, 2+ day ago (361+ words) 10x Genomics has announced the launch of Atera, a new in situ spatial biology platform designed to deliver whole-transcriptome spatial analysis with single-cell sensitivity at unprecedented scale. The company said the platform has been engineered to enable researchers to study gene…...
AI to antibody in days: breaking the wet lab bottleneck via high-throughput integration
3+ week, 1+ day ago (146+ words) The role of artificial intelligence (AI) in drug design has fundamentally shifted from a speculative tool to a central pillar of pharmaceutical research and development (R&D). Sino Biological plays a critical role in this evolving landscape by acting as an…...
Computational design drives new generation of synthetic promoters
1+ mon, 3+ day ago (856+ words) Designing gene control from scratch is becoming possible. Syn Gen Sys is using computational design to create synthetic promoters for advanced therapies. This work is led in part by Professor David James, co-founder of Syn Gen Sys and professor of…...
Physics-based modelling offers a new way to study drug targets
1+ mon, 5+ day ago (1273+ words) Proteins are often studied as static structures, yet they behave dynamically in living systems. Tiffanwy Klippel-Cooper of Omnigeni Q explains how physics-based modelling could help researchers better understand drug targets. A new approach emerging from Australian start-up Omnigeni Q aims…...
New AI-designed T-cell engager LGTX-101 to be presented at AACR in San Diego
1+ mon, 1+ week ago (314+ words) Lab Genius Therapeutics will present preclinical data for LGTX-101, its AI-designed Nectin-4 x CD3 T-cell engager, at AACR 2026 in San Diego. Lab Genius Therapeutics, a drug discovery company that combines artificial intelligence (AI), high-throughput experimentation and machine learning to develop next-generation…...
AAPS Summer Scientific Forum
1+ mon, 1+ week ago (189+ words) The AAPS Summer Scientific Forum brings scientists together to discuss innovative technologies, fresh approaches to current challenges, and key regulatory issues in bioanalysis and pharmaceutical analysis. The forum offers the opportunity to discuss the latest research in both areas and…...
Discovery is changing " and automation leads the way
1+ mon, 2+ week ago (1422+ words) Automation is helping drug discovery teams screen faster, cut costs and run complex assays at scale " but its real value lies in what happens next. Few events have tested laboratories like the COVID-19 pandemic. For Howes, it became a live…...
How self-driving labs are changing drug development
1+ mon, 2+ week ago (1141+ words) Automation and artificial intelligence are changing how scientists design, test and refine new molecules. At the University of Toronto, Stuart R Green and the Acceleration Consortium are building a self-driving lab that could change the pace of early drug discovery....